Thought Leadership

Patients in the Limelight: The Federal Circuit Applies Akamai v. Limelight to Divided Infringement in Healthcare

External Article

Stephen Maule published an article, “Patients in the Limelight: The Federal Circuit Applies Akamai v. Limelight to Divided Infringement in Healthcare” in the Intellectual Property & Technology Law Journal in its June 2017, Volume 29, Number 6 edition. The article examines that in the past few months, the U.S. Court of Appeals for the Federal Circuit decided two cases addressing the issue of divided patent infringement in the healthcare field. In both Medgraph, Inc. v. Medtronic, Inc. and Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., the Federal Circuit applied the Akamai standard for divided infringement to determine whether patient conduct may be attributed to a physician or third party when determining liability.

For a copy of this article click the title link below.

Patients in the Limelight: The Federal Circuit Applies Akamai v. Limelight to Divided Infringement in Healthcare

Related Professionals